DIVISLAB — Divi's Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.20tn
- IN₹1.16tn
- IN₹78.45bn
Annual cashflow statement for Divi's Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 18,195 | 26,660 | 36,835 | 23,686 | 21,630 |
| Depreciation | |||||
| Non-Cash Items | -1,262 | -663 | -718 | -1,982 | -2,970 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6,635 | -9,084 | -20,114 | -538 | -9,830 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 12,159 | 19,469 | 19,118 | 24,597 | 12,610 |
| Capital Expenditures | -11,832 | -9,102 | -7,132 | -4,730 | -10,030 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 10,997 | 9,853 | -14,817 | -22,346 | 7,340 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -835 | 751 | -21,949 | -27,076 | -2,690 |
| Financing Cash Flow Items | -61 | -8.7 | -3.6 | -3.3 | -20 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -10,914 | -349 | -5,324 | -7,972 | -7,990 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 411 | 19,872 | -8,156 | -10,451 | 1,930 |